Beaumont Financial Advisors’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $415K | Sell |
3,866
-161
| -4% | -$17.3K | 0.03% | 249 |
|
|
2025
Q1 | $406K | Sell |
4,027
-1,927
| -32% | -$194K | 0.03% | 250 |
|
|
2024
Q4 | $532K | Sell |
5,954
-94
| -2% | -$8.4K | 0.04% | 213 |
|
|
2024
Q3 | $507K | Buy |
6,048
+49
| +0.8% | +$4.11K | 0.04% | 212 |
|
|
2024
Q2 | $462K | Buy |
5,999
+192
| +3% | +$14.8K | 0.04% | 218 |
|
|
2024
Q1 | $398K | Buy |
5,807
+1,997
| +52% | +$137K | 0.03% | 235 |
|
|
2023
Q4 | $220K | Buy |
+3,810
| New | +$220K | 0.02% | 314 |
|
|
2021
Q4 | – | Sell |
-6,422
| Closed | -$279K | – | 355 |
|
|
2021
Q3 | $279K | Sell |
6,422
-99
| -2% | -$4.3K | 0.02% | 281 |
|
|
2021
Q2 | $279K | Sell |
6,521
-75
| -1% | -$3.21K | 0.02% | 305 |
|
|
2021
Q1 | $255K | Buy |
6,596
+8
| +0.1% | +$309 | 0.02% | 298 |
|
|
2020
Q4 | $237K | Buy |
+6,588
| New | +$237K | 0.02% | 304 |
|